Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Individual differences in extraversion and dopamine genetics predict neural reward responses.

Cohen MX, Young J, Baek JM, Kessler C, Ranganath C.

Brain Res Cogn Brain Res. 2005 Dec;25(3):851-61. Epub 2005 Nov 11.

PMID:
16289773
2.

Dopamine gene predicts the brain's response to dopaminergic drug.

Cohen MX, Krohn-Grimberghe A, Elger CE, Weber B.

Eur J Neurosci. 2007 Dec;26(12):3652-60.

PMID:
18088284
3.

Individual differences in reward-prediction-error: extraversion and feedback-related negativity.

Smillie LD, Cooper AJ, Pickering AD.

Soc Cogn Affect Neurosci. 2011 Oct;6(5):646-52. doi: 10.1093/scan/nsq078. Epub 2010 Sep 19.

4.

The effects of COMT (Val108/158Met) and DRD4 (SNP -521) dopamine genotypes on brain activations related to valence and magnitude of rewards.

Camara E, Krämer UM, Cunillera T, Marco-Pallarés J, Cucurell D, Nager W, Mestres-Missé A, Bauer P, Schüle R, Schöls L, Tempelmann C, Rodriguez-Fornells A, Münte TF.

Cereb Cortex. 2010 Aug;20(8):1985-96. doi: 10.1093/cercor/bhp263. Epub 2009 Dec 27.

5.

Neurobiology of the structure of personality: dopamine, facilitation of incentive motivation, and extraversion.

Depue RA, Collins PF.

Behav Brain Sci. 1999 Jun;22(3):491-517; discussion 518-69. Review.

PMID:
11301519
6.

Genetic variation in dopamine moderates neural response during reward anticipation and delivery: evidence from event-related potentials.

Foti D, Hajcak G.

Psychophysiology. 2012 May;49(5):617-26. doi: 10.1111/j.1469-8986.2011.01343.x. Epub 2012 Feb 15.

PMID:
22335281
7.

Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART).

Blum K, Chen TJ, Downs BW, Bowirrat A, Waite RL, Braverman ER, Madigan M, Oscar-Berman M, DiNubile N, Stice E, Giordano J, Morse S, Gold M.

Postgrad Med. 2009 Nov;121(6):176-96. doi: 10.3810/pgm.2009.11.2087. Review.

8.

Imaging gene-substance interactions: the effect of the DRD2 TaqIA polymorphism and the dopamine agonist bromocriptine on the brain activation during the anticipation of reward.

Kirsch P, Reuter M, Mier D, Lonsdorf T, Stark R, Gallhofer B, Vaitl D, Hennig J.

Neurosci Lett. 2006 Sep 25;405(3):196-201. Epub 2006 Aug 8.

PMID:
16901644
9.

Reward sensitivity and the D2 dopamine receptor gene: A case-control study of binge eating disorder.

Davis C, Levitan RD, Kaplan AS, Carter J, Reid C, Curtis C, Patte K, Hwang R, Kennedy JL.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 1;32(3):620-8. doi: 10.1016/j.pnpbp.2007.09.024. Epub 2007 Oct 10.

PMID:
18262320
10.

Reward deficiency syndrome: genetic aspects of behavioral disorders.

Comings DE, Blum K.

Prog Brain Res. 2000;126:325-41. Review.

PMID:
11105655
11.

Extraversion and striatal dopaminergic receptor availability in young adults: an [18F]fallypride PET study.

Baik SH, Yoon HS, Kim SE, Kim SH.

Neuroreport. 2012 Mar 7;23(4):251-4. doi: 10.1097/WNR.0b013e3283507533.

PMID:
22257904
12.

Resting posterior minus frontal EEG slow oscillations is associated with extraversion and DRD2 genotype.

Koehler S, Wacker J, Odorfer T, Reif A, Gallinat J, Fallgatter AJ, Herrmann MJ.

Biol Psychol. 2011 Jul;87(3):407-13. doi: 10.1016/j.biopsycho.2011.05.006. Epub 2011 Jun 7.

PMID:
21645585
13.
14.

Relationship between dopaminergic neurotransmission, alcoholism, and Reward Deficiency syndrome.

Bowirrat A, Oscar-Berman M.

Am J Med Genet B Neuropsychiatr Genet. 2005 Jan 5;132B(1):29-37. Review.

PMID:
15457501
15.

Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative dopamine D₂ agonist therapy: part 2.

Blum K, Chen TJ, Morse S, Giordano J, Chen AL, Thompson J, Allen C, Smolen A, Lubar J, Stice E, Downs BW, Waite RL, Madigan MA, Kerner M, Fornari F, Braverman ER.

Postgrad Med. 2010 Nov;122(6):214-26. doi: 10.3810/pgm.2010.11.2237.

PMID:
21084796
16.

Dissociation of neural networks for anticipation and consumption of monetary and social rewards.

Rademacher L, Krach S, Kohls G, Irmak A, Gründer G, Spreckelmeyer KN.

Neuroimage. 2010 Feb 15;49(4):3276-85. doi: 10.1016/j.neuroimage.2009.10.089. Epub 2009 Nov 12.

PMID:
19913621
17.

Acute intravenous synaptamine complex variant KB220™ "normalizes" neurological dysregulation in patients during protracted abstinence from alcohol and opiates as observed using quantitative electroencephalographic and genetic analysis for reward polymorphisms: part 1, pilot study with 2 case reports.

Miller DK, Bowirrat A, Manka M, Miller M, Stokes S, Manka D, Allen C, Gant C, Downs BW, Smolen A, Stevens E, Yeldandi S, Blum K.

Postgrad Med. 2010 Nov;122(6):188-213. doi: 10.3810/pgm.2010.11.2236. Review.

PMID:
21084795
18.

D2 dopamine receptor gene and cigarette smoking: a reward gene?

Noble EP, St Jeor ST, Ritchie T, Syndulko K, St Jeor SC, Fitch RJ, Brunner RL, Sparkes RS.

Med Hypotheses. 1994 Apr;42(4):257-60.

PMID:
8072432
19.

Dopamine modulates risk-taking as a function of baseline sensation-seeking trait.

Norbury A, Manohar S, Rogers RD, Husain M.

J Neurosci. 2013 Aug 7;33(32):12982-6. doi: 10.1523/JNEUROSCI.5587-12.2013.

20.

At-risk for pathological gambling: imaging neural reward processing under chronic dopamine agonists.

Abler B, Hahlbrock R, Unrath A, Grön G, Kassubek J.

Brain. 2009 Sep;132(Pt 9):2396-402. doi: 10.1093/brain/awp170. Epub 2009 Jun 30.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk